Hypoxia and GABA shunt activation in the pathogenesis of Alzheimer's disease

Neurochemistry International

Volumn 92, Issue , 2016, Pages 13-24

  Salminen, Antero ^a   Jouhten, Paula ^b,c   Sarajärvi, Timo ^a   Haapasalo, Annakaisa ^a,d   Hiltunen, Mikko ^a,d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Dementia; Energy metabolism; GABA shunt; GHB; Hypoxia

Indexed keywords

2,4 DIHYDROXYBUTYRATE; 4 AMINOBUTYRIC ACID; 4 HYDROXYBUTYRIC ACID; BUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; SUCCINATE SEMIALDEHYDE DEHYDROGENASE; UNCLASSIFIED DRUG; 2,4-DIHYDROXYBUTYRATE; BUTANEDIOL; BUTYRIC ACID DERIVATIVE; OXYBATE SODIUM;

ALZHEIMER DISEASE; BIOSYNTHESIS; BRAIN METABOLISM; DEGRADATION; HUMAN; HYPOXIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ANIMAL; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; ANIMALS; BUTYLENE GLYCOLS; BUTYRATES; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPOXIA; SODIUM OXYBATE;

EID: 84954126760     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2015.11.005     Document Type: Review

References (216)

1. P.A. Adlard, B.A. Tran, D.I. Finkelstein, P.M. Desmond, L.A. Johnston, A.I. Bush, and et al. A review of β-amyloid neuroimaging in Alzheimer's disease Front. Neurosci. 8 2014 327
2. S. Akaboshi, B.M. Hogema, A. Novelletto, P. Malaspina, G.S. Salomons, G.D. Maropoulos, and et al. Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency Hum. Mutat. 22 2003 442 450
3. R.W. Albers, and G.J. Koval Succinic semialdehyde dehydrogenase: purification and properties of the enzyme from monkey brain Biochim. Biophys. Acta 52 1961 29 35
4. S. Alzeer, and E.M. Ellis Metabolism of gamma hydroxybutyrate in human hepatoma HepG2 cells by the aldo-keto reductase AKR1A1 Biochem. Pharmacol. 92 2014 499 505
5. M.I. Ansari, S. Hasan, and S.U. Jalil Leaf senescence and GABA shunt Bioinformation 10 2014 734 736
6. J. Attems, F. Lintner, and K.A. Jellinger Amyloid β peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology Acta Neuropathol. 107 2004 283 291
7. B.P. Austin, V.A. Nair, T.B. Meier, G. Xu, H.A. Rowley, C.M. Carlsson, and et al. Effects of hypoperfusion in Alzheimer's disease J. Alzheimers Dis. 26 Suppl. 3 2011 123 133
8. L.K. Bak, A. Schousboe, and H.S. Waagepetersen The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer J. Neurochem. 98 2006 641 653
9. X. Bao, R. Pal, K.N. Hascup, Y. Wang, W.T. Wang, W. Xu, and et al. Transgenic expression of Glud1 (glutamate dehydrogenase 1) in neurons: in vivo model of enhanced glutamate release, altered synaptic plasticity, and selective neuronal vulnerability J. Neurosci. 29 2009 13929 13944
10. O.A. Barski, K.H. Gabbay, and K.M. Bohren Characterization of the human aldehyde reductase gene and promoter Genomics 60 1999 188 198
11. T. Bay, L.F. Eghorn, A.B. Klein, and P. Wellendorph GHB receptor targets in the CNS: focus on high-affinity binding sites Biochem. Pharmacol. 87 2014 220 228
12. N. Bouche, A. Fait, D. Bouchez, S.G. Moller, and H. Fromm Mitochondrial succinic-semialdehyde dehydrogenase of the gamma-aminobutyrate shunt is required to restrict levels of reactive oxygen intermediates in plants Proc. Natl. Acad. Sci. U. S. A. 100 2003 6843 6848
13. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. 82 1991 239 259
14. H. Braak, I. Alafuzoff, T. Arzberger, H. Kretzschmar, and K. Del Tredici Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry Acta Neuropathol. 112 2006 389 404
15. 2+ dependent Chem. Res. Toxicol. 20 2007 887 895
16. G.K. Brown, C.H. Cromby, N.J. Manning, and R.J. Pollitt Urinary organic acids in succinic semialdehyde dehydrogenase deficiency: evidence of alpha-oxidation of 4-hydroxybutyric acid, interaction of succinic semialdehyde with pyruvate dehydrogenase and possible secondary inhibition of mitochondrial beta-oxidation J. Inherit. Metab. Dis. 10 1987 367 375
17. D.F. Bu, M.G. Erlander, B.C. Hitz, N.J. Tillakaratne, D.L. Kaufman, C.B. Wagner-McPherson, and et al. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene Proc. Natl. Acad. Sci. U. S. A. 89 1992 2115 2119
18. P. Bubber, V. Haroutunian, G. Fisch, J.P. Blass, and G.E. Gibson Mitochondrial abnormalities in Alzheimer brain: mechanistic implications Ann. Neurol. 57 2005 695 703
19. G.Sh Burbaeva, I.S. Boksha, E.B. Tereshkina, O.K. Savushkina, L.I. Starodubtseva, and M.S. Turishcheva Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients Neurochem. Res. 30 2005 1443 1451
20. D.A. Butterfield, and C.B. Pocernich The glutamatergic system and Alzheimer's disease: therapeutic implications CNS Drugs 17 2003 641 652
21. D.A. Butterfield, M.L. Bader Lange, and R. Sultana Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease Biochim. Biophys. Acta 1801 2010 924 929
22. D.A. Butterfield, A. Castegna, C.M. Lauderback, and J. Drake Evidence that amyloid β-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death Neurobiol. Aging 23 2002 655 664
23. D.A. Butterfield, T. Reed, M. Perluigi, C. De Marco, R. Coccia, C. Cini, and et al. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment Neurosci. Lett. 397 2006 170 173
24. C.C. Caldwell, J. Yao, and R.D. Brinton Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities Neurotherapeutics 12 2015 66 80
25. C.D. Cash, M. Maitre, and P. Mandel Purification from human brain and some properties of two NADPH-linked aldehyde reductases which reduce succinic semialdehyde to 4-hydroxybutyrate J. Neurochem. 33 1979 1169 1175
26. K.L. Chambliss, D.L. Caudle, D.D. Hinson, C.R. Moomaw, C.A. Slaughter, C. Jakobs, and et al. Molecular cloning of the mature NAD+-dependent succinic semialdehyde dehydrogenase from rat and human. cDNA isolation, evolutionary homology, and tissue expression J. Biol. Chem. 270 1995 461 467
27. K. Chandrasekaran, K. Hatanpää, D.R. Brady, J. Stoll, and S.I. Rapoport Downregulation of oxidative phosphorylation in Alzheimer disease: loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex Brain Res. 796 1998 13 19
28. A. Charidimou, and D.J. Werring Cerebral microbleeds and cognition in cerebrovascular disease: an update J. Neurol. Sci. 322 2012 50 55
29. Y. Chen, E. Dong, and D.R. Grayson Analysis of the GAD1 promoter: trans-acting factors and DNA methylation converge on the 5' untranslated region Neuropharmacology 60 2011 1075 1087
30. C. Chinopoulos Which way does the citric acid cycle turn during hypoxia? the critical role of α-ketoglutarate dehydrogenase complex J. Neurosci. Res. 91 2013 1030 1043
31. S.W. Cho, M.S. Song, G.Y. Kim, W.D. Kang, E.Y. Choi, and S.Y. Choi Kinetics and mechanism of an NADPH-dependent succinic semialdehyde reductase from bovine brain Eur. J. Biochem. 211 1993 757 762
32. V. Crunelli, Z. Emri, and N. Leresche Unravelling the brain targets of γ-hydroxybutyric acid Curr. Opin. Pharmacol. 6 2006 44 52
33. S. Cunnane, S. Nugent, M. Roy, A. Courchesne-Loyer, E. Croteau, S. Tremblay, and et al. Brain fuel metabolism, aging, and Alzheimer's disease Nutrition 27 2011 3 20
34. C. Czech, P. Berndt, K. Busch, O. Schmitz, J. Wiemer, V. Most, and et al. Metabolite profiling of Alzheimer's disease cerebrospinal fluid PLoS One 7 2012 e31501
35. W. Danysz, and C.G. Parsons Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine - searching for the connections Br. J. Pharmacol. 167 2012 324 352
36. R.A. de Graaf, A.B. Patel, D.L. Rothman, and K.L. Behar Acute regulation of steady-state GABA levels following GABA-transaminase inhibition in rat cerebral cortex Neurochem. Int. 48 2006 508 514
37. B.C. Dickerson, D.A. Wolk, and Alzheimer's Disease Neuroimaging Initiative Biomarker-based prediction of progression in MCI: comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau Front. Aging Neurosci. 5 2013 55
38. J.D. Doherty, and R.H. Roth Metabolism of γ-hydroxy-[1-14C] butyrate by rat brain: relationship to the Krebs cycle and metabolic compartmentation of amino acids J. Neurochem. 30 1978 1305 1309
39. K.J. Drake, V.Y. Sidorov, O.P. McGuinness, D.H. Wasserman, and J.P. Wikswo Amino acids as metabolic substrates during cardiac ischemia Exp. Biol. Med. (Maywood) 237 2012 1369 1378
40. M. Dumont, D.J. Ho, N.Y. Calingasan, H. Xu, G. Gibson, and M.F. Beal Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition Free Radic. Biol. Med. 47 2009 1019 1027
41. M.G. Erlander, N.J. Tillakaratne, S. Feldblum, N. Patel, and A.J. Tobin Two genes encode distinct glutamate decarboxylases Neuron 7 1991 91 100
42. M. Esclapez, N.J. Tillakaratne, D.L. Kaufman, A.J. Tobin, and C.R. Houser Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms J. Neurosci. 14 1994 1834 1855
43. S.F. Eskildsen, P. Coupe, V.S. Fonov, J.C. Pruessner, D.L. Collins, and Alzheimer's Disease Neuroimaging Initiative Structural imaging biomarkers of Alzheimer's disease: predicting disease progression Neurobiol. Aging 36 Suppl. 1 2015 S23 S31
44. A. Fait, H. Fromm, D. Walter, G. Galili, and A.R. Fernie Highway or byway: the metabolic role of the GABA shunt in plants Trends Plant Sci. 13 2008 14 19
45. C. Feehily, and K.A. Karatzas Role of glutamate metabolism in bacterial responses towards acid and other stresses J. Appl. Microbiol. 114 2013 11 24
46. D. Ferreira, L. Perestelo-Perez, E. Westman, L.O. Wahlund, A. Sarria, and P. Serrano-Aguilar Meta-review of CSF core biomarkers in Alzheimer's disease: the state-of-the-art after the new revised diagnostic criteria. Front Aging Neurosci. 6 2014 47
47. G.E. Gibson, J.P. Blass, M.F. Beal, and V. Bunik The α-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration Mol. Neurobiol. 31 2005 43 63
48. K.M. Gibson, and W.L. Nyhan Metabolism of [U-14C]-4-hydroxybutyric acid to intermediates of the tricarboxylic acid cycle in extracts of rat liver and kidney mitochondria Eur. J. Drug Metab. Pharmacokinet. 14 1989 61 70
49. M.Y. Globus, R. Busto, E. Martinez, I. Valdes, W.D. Dietrich, and M.D. Ginsberg Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat J. Neurochem. 57 1991 470 478
50. R. Gonzalez-Dominguez, T. Garcia-Barrera, J. Vitorica, and J.L. Gomez-Ariza Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry J. Pharm. Biomed. Anal. 102 2015 425 435
51. N. Gordon Succinic semialdehyde dehydrogenase deficiency (SSADH) (4-hydroxybutyric aciduria, gamma-hydroxybutyric aciduria) Eur. J. Paediatr. Neurol. 8 2004 261 265
52. S.M. Grant, and R.C. Heel Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control Drugs 41 1991 889 926
53. F. Guneral, and C. Bachmann Age-related reference values for urinary organic acids in a healthy Turkish pediatric population Clin. Chem. 40 1994 862 866
54. E.J. Hammond, and B.J. Wilder Gamma-vinyl GABA Gen. Pharmacol. 16 1985 441 447
55. H. Hampel, K. Burger, S.J. Teipel, A.L. Bokde, H. Zetterberg, and K. Blennow Core candidate neurochemical and imaging biomarkers of Alzheimer's disease Alzheimers Dement. 4 2008 38 48
56. H. Hampel, S.J. Teipel, T. Fuchsberger, N. Andreasen, J. Wiltfang, M. Otto, and et al. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment Mol. Psychiatry 9 2004 705 710
57. A.L. Hartman, M. Gasior, E.P. Vining, and M.A. Rogawski The neuropharmacology of the ketogenic diet Pediatr. Neurol. 36 2007 281 292
58. B. Hassel, C.U. Johannessen, U. Sonnewald, and F. Fonnum Quantification of the GABA shunt and the importance of the GABA shunt versus the 2-oxoglutarate dehydrogenase pathway in GABAergic neurons J. Neurochem. 71 1998 1511 1518
59. W.G. Hearl, and J.E. Churchich Interactions between 4-aminobutyrate aminotransferase and succinic semialdehyde dehydrogenase, two mitochondrial enzymes J. Biol. Chem. 259 1984 11459 11463
60. G.F. Hoffmann, W. Meier-Augenstein, S. Stöckler, R. Surtees, D. Rating, and W.L. Nyhan Physiology and pathophysiology of organic acids in cerebrospinal fluid J. Inherit. Metab. Dis. 16 1993 648 669
61. W. Hu, C. Zhang, R. Wu, Y. Sun, A. Levine, and Z. Feng Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function Proc. Natl. Acad. Sci. U. S. A. 107 2010 7455 7460
62. I.K. Hwang, K.Y. Yoo, D.S. Kim, W.S. Eum, J.K. Park, J. Park, and et al. Changes of pyridoxal kinase expression and activity in the gerbil hippocampus following transient forebrain ischemia Neuroscience 128 2004 511 518
63. C.R. Jack Jr., and D.M. Holtzman Biomarker modeling of Alzheimer's disease Neuron 80 2013 1347 1358
64. A.R. Jayakumar, R. Sujatha, V. Paul, C. Asokan, S. Govindasamy, and R. Jayakumar Role of nitric oxide on GABA, glutamic acid, activities of GABA-T and GAD in rat brain cerebral cortex Brain Res. 837 1999 229 235
65. B. Jeynes, and J. Provias The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison Acta Neuropathol. 112 2006 417 427
66. S. Jo, O. Yarishkin, Y.J. Hwang, Y.E. Chun, M. Park, D.H. Woo, and et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease Nat. Med. 20 2014 886 896
67. J. Johansson, A. Grönbladh, and M. Hallberg Gamma-hydroxybutyrate (GHB) induces cognitive deficits and affects GABAB receptors and IGF-1 receptors in male rats Behav. Brain Res. 269 2014 164 174
68. R.N. Kalaria The role of cerebral ischemia in Alzheimer's disease Neurobiol. Aging 21 2000 321 330
69. J. Kanaani, M.J. Diacovo, A. El-Husseini, D.S. Bredt, and S. Baekkeskov Palmitoylation controls trafficking of GAD65 from Golgi membranes to axon-specific endosomes and a Rab5a-dependent pathway to presynaptic clusters J. Cell Sci. 117 2004 2001 2013
70. J. Kanaani, J. Kolibachuk, H. Martinez, and S. Baekkeskov Two distinct mechanisms target GAD67 to vesicular pathways and presynaptic clusters J. Cell Biol. 190 2010 911 925
71. T.C. Kang, S.K. Park, J.H. Bahn, J.S. Chang, W.S. Koh, S.M. Jo, and et al. Elevation of the γ-aminobutyric acid transaminase expression in the gerbil CA1 area after ischemia-reperfusion damage Neurosci. Lett. 294 2000 33 36
72. T.C. Kang, S.K. Park, I.K. Hwang, S.J. An, S.Y. Choi, S.W. Cho, and et al. Spatial and temporal alterations in the GABA shunt in the gerbil hippocampus following transient ischemia Brain Res. 944 2002 10 18
73. T.C. Kang, S.K. Park, I.K. Hwang, S.J. An, S.Y. Choi, O.S. Kwon, and et al. The altered expression of GABA shunt enzymes in the gerbil hippocampus before and after seizure generation Neurochem. Int. 42 2003 239 249
74. E.E. Kaufman, and T. Nelson An overview of γ-hydroxybutyrate catabolism: the role of the cytosolic NADP(+)-dependent oxidoreductase EC 1.1.1.19 and of a mitochondrial hydroxyacid-oxoacid transhydrogenase in the initial, rate-limiting step in this pathway Neurochem. Res. 16 1991 965 974
75. V.P. Kelly, P.J. Sherratt, D.H. Crouch, and J.D. Hayes Novel homodimeric and heterodimeric rat γ-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins Biochem. J. 366 2002 847 861
76. V. Kemmel, C. Klein, D. Dembele, B. Jost, O. Taleb, D. Aunis, and et al. A single acute pharmacological dose of γ-hydroxybutyrate modifies multiple gene expression patterns in rat hippocampus and frontal cortex Physiol. Genomics 41 2010 146 160
77. J.W. Kim, I. Tchernyshyov, G.L. Semenza, and C.V. Dang HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia Cell. Metab. 3 2006 177 185
78. K.J. Kim, P.L. Pearl, K. Jensen, O.C. Snead, P. Malaspina, C. Jakobs, and et al. Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance Antioxid. Redox Signal 15 2011 691 718
79. Y.G. Kim, S. Lee, O.S. Kwon, S.Y. Park, S.J. Lee, B.J. Park, and et al. Redox-switch modulation of human SSADH by dynamic catalytic loop EMBO J. 28 2009 959 968
80. S.J. Kish, C. Bergeron, A. Rajput, S. Dozic, F. Mastrogiacomo, Chang, and et al. Brain cytochrome oxidase in Alzheimer's disease J. Neurochem. 59 1992 776 779
81. C. Klein, V. Kemmel, O. Taleb, D. Aunis, and M. Maitre Pharmacological doses of γ-hydroxybutyrate (GHB) potentiate histone acetylation in the rat brain by histone deacetylase inhibition Neuropharmacology 57 2009 137 147
82. C. Klein, C. Mathis, G. Leva, C. Patte-Mensah, J.C. Cassel, M. Maitre, and et al. γ-Hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer's disease Neurobiol. Aging 36 2015 832 844
83. L.W. Ko, K.F. Sheu, H.T. Thaler, W.R. Markesbery, and J.P. Blass Selective loss of KGDHC-enriched neurons in Alzheimer temporal cortex: does mitochondrial variation contribute to selective vulnerability? J. Mol. Neurosci. 17 2001 361 369
84. M. Kranendijk, E.A. Struys, G.S. Salomons, M.S. Van der Knaap, and C. Jakobs Progress in understanding 2-hydroxyglutaric acidurias J. Inherit. Metab. Dis. 35 2012 571 587
85. M. Kulijewicz-Nawrot, E. Sykova, A. Chvatal, A. Verkhratsky, and J.J. Rodriguez Astrocytes and glutamate homoeostasis in Alzheimer's disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex ASN Neuro 5 2013 273 282
86. K.L. Lanctot, N. Herrmann, P. Mazzotta, L.R. Khan, and N. Ingber GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia Can. J. Psychiatry 49 2004 439 453
87. A. Latini, K. Scussiato, G. Leipnitz, K.M. Gibson, and M. Wajner Evidence for oxidative stress in tissues derived from succinate semialdehyde dehydrogenase-deficient mice J. Inherit. Metab. Dis. 30 2007 800 810
88. C.R. Lee Evidence for the β-oxidation of orally administered 4-hydroxybutyrate in humans Biochem. Med. 17 1977 284 291
89. M. Lee, C. Schwab, and P.L. McGeer Astrocytes are GABAergic cells that modulate microglial activity Glia 59 2011 152 165
90. W.C. Lee, H.Y. Wong, Y.Y. Chai, C.W. Shi, N. Amino, S. Kikuchi, and et al. Lipid peroxidation dysregulation in ischemic stroke: plasma 4-HNE as a potential biomarker? Biochem. Biophys. Res. Commun. 425 2012 842 847
91. C. Li, and R.M. Jackson Reactive species mechanisms of cellular hypoxia-reoxygenation injury Am. J. Physiol. Cell Physiol. 282 2002 C227 C241
92. Y. Li, G.D. Blanco, Z. Lei, and Z.C. Xu Increased GAD expression in the striatum after transient cerebral ischemia Mol. Cell. Neurosci. 45 2010 370 377
93. J. Liu, C. Zhang, M. Lin, W. Zhu, Y. Liang, X. Hong, and et al. Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma Oncotarget 5 2014 2635 2647
94. L.D. Longo, S. Packianathan, J.A. McQueary, R.B. Stagg, C.V. Byus, and C.D. Cain Acute hypoxia increases ornithine decarboxylase activity and polyamine concentrations in fetal rat brain Proc. Natl. Acad. Sci. U. S. A. 90 1993 692 696
95. G. Luca, J. Vienne, A. Vaucher, S. Jimenez, and M. Tafti Central and peripheral metabolic changes induced by γ-hydroxybutyrate Sleep 38 2015 305 313
96. C. Luckhaus, M.O. Flub, H.J. Wittsack, B. Grass-Kapanke, M. Jänner, R. Khalili-Amiri, and et al. Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging Neuroimage 40 2008 495 503
97. R.C. Lyon, S.M. Johnston, D.G. Watson, G. McGarvie, and E.M. Ellis Synthesis and catabolism of γ-hydroxybutyrate in SH-SY5Y human neuroblastoma cells: role of the aldo-keto reductase AKR7A2 J. Biol. Chem. 282 2007 25986 25992
98. J.E. Madl, and S.M. Royer Glutamate dependence of GABA levels in neurons of hypoxic and hypoglycemic rat hippocampal slices Neuroscience 96 2000 657 664
99. M. Maitre The γ-hydroxybutyrate signalling system in brain: organization and functional implications Prog. Neurobiol. 51 1997 337 361
100. P. Malaspina, M.J. Picklo, C. Jakobs, O.C. Snead, and K.M. Gibson Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of γ-hydroxybutyrate associated with its deficiency Hum. Genomics 3 2009 106 120
101. M. Mamelak Sporadic Alzheimer's disease: the starving brain J. Alzheimers Dis. 31 2012 459 474
102. M. Mamelak Alzheimer's disease, oxidative stress and γ-hydroxybutyrate Neurobiol. Aging 28 2007 1340 1360
103. M. Mapstone, A.K. Cheema, M.S. Fiandaca, X. Zhong, T.R. Mhyre, L.H. MacArthur, and et al. Plasma phospholipids identify antecedent memory impairment in older adults Nat. Med. 20 2014 415 418
104. W.R. Markesbery Oxidative stress hypothesis in Alzheimer's disease Free Radic. Biol. Med. 23 1997 134 147
105. D.L. Martin Regulatory properties of brain glutamate decarboxylase Cell. Mol. Neurobiol. 7 1987 237 253
106. E. Martin, R.E. Rosenthal, and G. Fiskum Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress J. Neurosci. Res. 79 2005 240 247
107. F. Mastrogiacomo, C. Bergeron, and S.J. Kish Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease J. Neurochem. 61 1993 2007 2014
108. I. Maurer, S. Zierz, and H.J. Möller A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients Neurobiol. Aging 21 2000 455 462
109. J. McConathy, and Y.I. Sheline Imaging biomarkers associated with cognitive decline: a review Biol. Psychiatry 77 2015 685 692
110. M.C. McKenna The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain J. Neurosci. Res. 85 2007 3347 3358
111. E. McKracken, D.I. Graham, M. Nilsen, J. Stewart, J.A. Nicoll, and K. Horsburgh 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia Brain Pathol. 11 2001 414 421
112. B.S. Meldrum Glutamate as a neurotransmitter in the brain: review of physiology and pathology J. Nutr. 130 2000 1007S 1015S
113. S. Michaeli, A. Fait, K. Lagor, A. Nunes-Nesi, N. Grillich, A. Yellin, and et al. A mitochondrial GABA permease connects the GABA shunt and the TCA cycle, and is essential for normal carbon metabolism Plant J. 67 2011 485 498
114. J.W. Miller, R. Green, D.M. Mungas, B.R. Reed, and W.J. Jagust Homocysteine, vitamin B6, and vascular disease in AD patients Neurology 58 2002 1471 1475
115. R.D. Mindnich, and T.M. Penning Aldo-keto reductase (AKR) superfamily: genomics and annotation Hum. Genomics 3 2009 362 370
116. R. Minocha, R. Majumdar, and S.C. Minocha Polyamines and abiotic stress in plants: a complex relationship Front. Plant Sci. 5 2014 175
117. N. Minois, D. Carmona-Gutierrez, and F. Madeo Polyamines in aging and disease Aging (Albany NY) 3 2011 716 732
118. A.C. Mitchell, Y. Jiang, C. Peter, and S. Akbarian Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia Schizophr. Res. 167 2015 28 34
119. L.D. Morrison, and S.J. Kish Brain polyamine levels are altered in Alzheimer's disease Neurosci. Lett. 197 1995 5 8
120. L.D. Morrison, C. Bergeron, and S.J. Kish Brain S-adenosylmethionine decarboxylase activity is increased in Alzheimer's disease Neurosci. Lett. 154 1993 141 144
121. M. Mousavi, P. Jonsson, H. Antti, R. Adolfsson, A. Nordin, J. Bergdahl, and et al. Serum metabolomic biomarkers of dementia Dement. Geriatr. Cogn. Dis. Extra 4 2014 252 262
122. H. Möhler, A.J. Patel, and R. Balazs γ-Hydroxybutyrate degradation in the brain in vivo: negligible direct conversion to GABA J. Neurochem. 27 1976 253 258
123. B.B. Mrsulja, B.J. Mrsulja, V. Cvejic, B.M. Djuriciic, and L. Rogac Alterations of putative neurotransmitters and enzymes during ischemia in gerbil cerebral cortex J. Neural Transm. Suppl. 14 1978 23 30
124. T.C. Murphy, V. Amarnath, K.M. Gibson, and M.J. Picklo Sr. Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A) J. Neurochem. 86 2003 298 305
125. G.J. Müller, A.M. Dogonowski, B. Finsen, and F.F. Johansen Expression of glutamic acid decarboxylase and identification of GABAergic cells in the ischemic rat dentate gyrus Exp. Brain Res. 175 2006 556 566
126. I. Müller, G. Caliskan, and O. Stork The GAD65 knock out mouse - a model for GABAergic processes in fear- and stress-induced psychopathology Genes Brain Behav. 14 2015 37 45
127. J. Myllyharju, and P. Koivunen Hypoxia-inducible factor prolyl 4-hydroxylases: common and specific roles Biol. Chem. 394 2013 435 448
128. Z. Nagy, M.M. Esiri, M. LeGris, and P.M. Matthews Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology Acta Neuropathol. 97 1999 346 354
129. F.A. Nasrallah, A.D. Maher, J.R. Hanrahan, V.J. Balcar, and C.D. Rae γ-Hydroxybutyrate and the GABAergic footprint: a metabolomic approach to unpicking the actions of GHB J. Neurochem. 115 2010 58 67
130. E. Nguyen, and M.J. Picklo Sr Inhibition of succinic semialdehyde dehydrogenase activity by alkenal products of lipid peroxidation Biochim. Biophys. Acta 1637 2003 107 112
131. M.J. Niciu, B. Kelmendi, and G. Sanacora Overview of glutamatergic neurotransmission in the nervous system Pharmacol. Biochem. Behav. 100 2012 656 664
132. M. Olabarria, H.N. Noristani, A. Verkhratsky, and J.J. Rodríguez Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission? Mol. Neurodegener. 6 2011 55
133. M. Oresic, T. Hyötyläinen, S.K. Herukka, M. Sysi-Aho, I. Mattila, T. Seppänen-Laakso, and et al. Metabolome in progression to Alzheimer's disease Transl. Psychiatry 1 2011 e57
134. A. Ottani, S. Saltini, M. Bartiromo, D. Zaffe, A. Renzo Botticelli, A. Ferrari, and et al. Effect of γ-hydroxybutyrate in two rat models of focal cerebral damage Brain Res. 986 2003 181 190
135. A. Ottani, A.V. Vergoni, S. Saltini, C. Mioni, D. Giuliani, M. Bartiromo, and et al. Effect of late treatment with γ-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat Eur. J. Pharmacol. 485 2004 183 191
136. J.B. Owen, F. Di Domenico, R. Sultana, M. Perluigi, C. Cini, W.M. Pierce, and et al. Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD J. Proteome Res. 8 2009 471 482
137. W.D. Parker Jr., J. Parks, C.M. Filley, and B.K. Kleinschmidt-DeMasters Electron transport chain defects in Alzheimer's disease brain Neurology 44 1994 1090 1096
138. J.M. Pascual, F. Carceller, J.M. Roda, and S. Cerdan Glutamate, glutamine, and GABA as substrates for the neuronal and glial compartments after focal cerebral ischemia in rats Stroke 29 1998 1048 1056
139. S. Passarella, A. Atlante, M. Barile, and E. Quagliariello Carrier mediated GABA translocation into rat brain mitochondria Biochem. Biophys. Res. Commun. 121 1984 770 778
140. P.L. Pearl, K.M. Gibson, M.A. Cortez, Y. Wu, O. Carter Snead 3rd, I. Knerr, and et al. Succinic semialdehyde dehydrogenase deficiency: lessons from mice and men J. Inherit. Metab. Dis. 32 2009 343 352
141. M.J. Picklo Sr., S.J. Olson, J.D. Hayes, W.R. Markesbery, and T.J. Montine Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerative disease Brain Res. 916 2001 229 238
142. R. Pluta, M. Jablonski, M. Ulamek-Koziol, J. Kocki, J. Brzozowska, S. Januszewski, and et al. Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes Mol. Neurobiol. 48 2013 500 515
143. P.J. Ratcliffe Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer J. Physiol. 591 2013 2027 2042
144. T.T. Reed, W.M. Pierce Jr., D.M. Turner, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule J. Cell. Mol. Med. 13 2009 2019 2029
145. T.T. Reed, W.M. Pierce, W.R. Markesbery, and D.A. Butterfield Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD Brain Res. 1274 2009 66 76
146. Z.J. Reitman, and H. Yan Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism J. Natl. Cancer Inst. 102 2010 932 941
147. T.J. Revett, G.B. Baker, J. Jhamandas, and S. Kar Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology J. Psychiatry Neurosci. 38 2013 6 23
148. S.R. Robinson Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes Neurochem. Int. 36 2000 471 482
149. R. Rognstad, and J. Katz Effects of 2,4-dihydroxybutyrate on lipogenesis in rat hepatocytes J. Biol. Chem. 254 1979 11969 11972
150. S.S. Santos, G.E. Gibson, A.J. Cooper, T.T. Denton, C.M. Thompson, V.I. Bunik, and et al. Inhibitors of the α-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons J. Neurosci. Res. 83 2006 450 458
151. M. Schaller, M. Schaffhauser, N. Sans, and B. Wermuth Cloning and expression of succinic semialdehyde reductase from human brain. Identity with aflatoxin B1 aldehyde reductase Eur. J. Biochem. 265 1999 1056 1060
152. M.I. Schimerlik, and W.W. Cleland Inhibition and alternate-substrate studies on the mechanism of malic enzyme Biochemistry 16 1977 565 570
153. C. Schneider, N.A. Porter, and A.R. Brash Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation J. Biol. Chem. 283 2008 15539 15543
154. A. Schousboe, L.K. Bak, and H.S. Waagepetersen Astrocytic control of biosynthesis and turnover of the neurotransmitters glutamate and GABA Front. Endocrinol. (Lausanne) 4 2013 102
155. A. Schousboe, U. Sonnewald, and H.S. Waagepetersen Differential roles of alanine in GABAergic and glutamatergic neurons Neurochem. Int. 43 2003 311 315
156. A. Schousboe, J.Y. Wu, and E. Roberts Subunit structure and kinetic properties of 4-aminobutyrate-2-ketoglutarate transaminase purified from mouse brain J. Neurochem. 23 1974 1189 1195
157. I. Schousboe, B. Bro, and A. Schousboe Intramitochondrial localization of the 4-aminobutyrate-2-oxoglutarate transaminase from ox brain Biochem. J. 162 1977 303 307
158. R.D. Schwartz-Bloom, and R. Sah γ-Aminobutyric acid (A) neurotransmission and cerebral ischemia J. Neurochem. 77 2001 353 371
159. R. Seidl, S. Beninati, N. Cairns, N. Singewald, D. Risser, H. Bavan, and et al. Polyamines in frontal cortex of patients with Down syndrome and Alzheimer disease Neurosci. Lett. 206 1996 193 195
160. R. Seidl, N. Cairns, N. Singewald, S.T. Kaehler, and G. Lubec Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology Naunyn Schmiedeb. Arch. Pharmacol. 363 2001 139 145
161. G.L. Semenza Hypoxia-inducible factors in physiology and medicine Cell 148 2012 399 408
162. J.Y. Seo, C.H. Lee, J.H. Cho, J.H. Choi, K.Y. Yoo, D.W. Kim, and et al. Neuroprotection of ebselen against ischemia/reperfusion injury involves GABA shunt enzymes J. Neurol. Sci. 285 2009 88 94
163. B.J. Shelp, A.W. Bown, and M.D. McLean Metabolism and functions of γ-aminobutyric acid Trends Plant Sci. 4 1999 446 452
164. F. Sherif, C.G. Gottfries, I. Alafuzoff, and L. Oreland Brain γ-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease J. Neural Transm. Park. Dis. Dement. Sect. 4 1992 227 240
165. K.F. Sheu, and J.P. Blass The α-ketoglutarate dehydrogenase complex Ann. N. Y. Acad. Sci. 893 1999 61 78
166. Q. Shi, O. Risa, U. Sonnewald, and G.E. Gibson Mild reduction in the activity of the α-ketoglutarate dehydrogenase complex elevates GABA shunt and glycolysis J. Neurochem. 109 Suppl. 1 2009 214 221
167. Q. Shi, H. Xu, W.A. Kleinman, and G.E. Gibson Novel functions of the α-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease Biochim. Biophys. Acta 1782 2008 229 238
168. T. Shinka, Y. Inoue, M. Ohse, A. Ito, M. Ohfu, S. Hirose, and et al. Rapid and sensitive detection of urinary 4-hydroxybutyric acid and its related compounds by gas chromatography-mass spectrometry in a patient with succinic semialdehyde dehydrogenase deficiency J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 776 2002 57 63
169. A. Shuaib, S. Ijaz, S. Hasan, and J. Kalra γ-Vinyl GABA prevents hippocampal and substantia nigra reticulata damage in repetitive transient forebrain ischemia Brain Res. 590 1992 13 17
170. A. Shuaib, M.A. Murabit, R. Kanthan, W. Howlett, and T. Wishart The neuroprotective effects of γ-vinyl GABA in transient global ischemia: a morphological study with early and delayed evaluations Neurosci. Lett. 204 1996 1 4
171. N.A. Simonian, and B.T. Hyman Functional alterations in Alzheimer's disease: diminution of cytochrome oxidase in the hippocampal formation J. Neuropathol. Exp. Neurol. 52 1993 580 585
172. J.J. Soghomonian, and D.L. Martin Two isoforms of glutamate decarboxylase: why? Trends Pharmacol. Sci. 19 1998 500 505
173. U. Sonnewald Glutamate synthesis has to be matched by its degradation - where do all the carbons go? J. Neurochem. 131 2014 399 406
174. S. Sookoian, and C.J. Pirola Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome World J. Gastroenterol. 18 2012 3775 3781
175. S. Sorbi, E.D. Bird, and J.P. Blass Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain Ann. Neurol. 13 1983 72 78
176. M.P. Stoop, L. Coulier, T. Rosenling, S. Shi, A.M. Smolinska, L. Buydens, and et al. Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples Mol. Cell. Proteomics 9 2010 2063 2075
177. D.F. Stowe, and A.K. Camara Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function Antioxid. Redox Signal 11 2009 1373 1414
178. E.A. Struys, N.M. Verhoeven, E.E. Jansen, H.J. Ten Brink, M. Gupta, T.G. Burlingame, and et al. Metabolism of γ-hydroxybutyrate to d-2-hydroxyglutarate in mammals: further evidence for d-2-hydroxyglutarate transhydrogenase Metabolism 55 2006 353 358
179. R. Sultana, M. Perluigi, and D.A. Butterfield Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain Free Radic. Biol. Med. 62 2013 157 169
180. Y. Suzuki, H. Takahashi, M. Fukuda, H. Hino, K. Kobayashi, J. Tanaka, and et al. β-Hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes Brain Res. 1268 2009 17 23
181. C.H. Tae, K.J. Ryu, S.H. Kim, H.C. Kim, H.K. Chun, B.H. Min, and et al. Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation BMC Cancer 13 2013 142
182. J.A. Thompson, S.P. Markey, and P.V. Fennessey Gas-chromatographic/mass-spectrometric identification and quantitation of tetronic and deoxytetronic acids in urine from normal adults and neonates Clin. Chem. 21 1975 1892 1898
183. N.J. Tillakaratne, L. Medina-Kauwe, and K.M. Gibson γ-Aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues Comp. Biochem. Physiol. A. Physiol. 112 1995 247 263
184. L. Tretter, and V. Adam-Vizi Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of α-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress J. Neurosci. 20 2000 8972 8979
185. L. Tretter, and V. Adam-Vizi Inhibition of α-ketoglutarate dehydrogenase due to H2O2-induced oxidative stress in nerve terminals Ann. N. Y. Acad. Sci. 893 1999 412 416
186. L.K. Trofimova, W.L. Araujo, A.A. Strokina, A.R. Fernie, L. Bettendorff, and V.I. Bunik Consequences of the α-ketoglutarate dehydrogenase inhibition for neuronal metabolism and survival: implications for neurodegenerative diseases Curr. Med. Chem. 19 2012 5895 5906
187. E. Trushina, T. Dutta, X.M. Persson, M.M. Mielke, and R.C. Petersen Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics PLoS One 8 2013 e63644
188. E. Trushina, E. Nemutlu, S. Zhang, T. Christensen, J. Camp, J. Mesa, and et al. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease PLoS One 7 2012 e32737
189. J.G. van Amsterdam, T.M. Brunt, M.T. McMaster, and R.J. Niesink Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose Neurosci. Biobehav. Rev. 36 2012 1217 1227
190. R.H. van den Heuvel, B. Curti, M.A. Vanoni, and A. Mattevi Glutamate synthase: a fascinating pathway from L-glutamine to L-glutamate Cell. Mol. Life Sci. 61 2004 669 681
191. P. Vayer, J.D. Ehrhardt, S. Gobaille, P. Mandel, and M. Maitre γ-Hydroxybutyrate distribution and turnover rates in discrete brain regions of the rat Neurochem. Int. 12 1988 53 59
192. T. Velletri, F. Romeo, P. Tucci, A. Peschiaroli, M. Annicchiarico-Petruzzelli, M.V. Niklison-Chirou, and et al. GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation Cell Cycle 12 2013 3564 3573
193. M.M. Verbeek, I. Otte-Höller, R. Veerhuis, D.J. Ruiter, and R.M. De Waal Distribution of Aβ-associated proteins in cerebrovascular amyloid of Alzheimer's disease Acta Neuropathol. 96 1998 628 636
194. A.V. Vergoni, A. Ottani, A.R. Botticelli, D. Zaffe, L. Guano, A. Loche, and et al. Neuroprotective effect of γ-hydroxybutyrate in transient global cerebral ischemia in the rat Eur. J. Pharmacol. 397 2000 75 84
195. H.S. Waagepetersen, U. Sonnewald, and A. Schousboe The GABA paradox: multiple roles as metabolite, neurotransmitter, and neurodifferentiative agent J. Neurochem. 73 1999 1335 1342
196. S.S. Walkenstein, R. Wiser, C. Gudmundsen, and H. Kimmel Metabolism of γ-hydroxybutyric acid Biochim. Biophys. Acta 86 1964 640 642
197. J.M. Walsh, and J.B. Clark Studies on the control of 4-aminobutyrate metabolism in 'synaptosomal' and free rat brain mitochondria Biochem. J. 160 1976 147 157
198. J. Wang, J.T. Yu, M.S. Tan, T. Jiang, and L. Tan Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy Ageing Res. Rev. 12 2013 1024 1041
199. J. Wei, and J.Y. Wu Post-translational regulation of L-glutamic acid decarboxylase in the brain Neurochem. Res. 33 2008 1459 1465
200. D. Weissmann-Nanopoulos, M.F. Belin, P. Mandel, and M. Maitre Immunocytochemical evidence for the presence of enzymes synthesizing GABA and GHB in the same neuron Neurochem. Int. 6 1984 333 338
201. C.E. Wierenga, C.C. Hays, and Z.Z. Zlatar Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease J. Alzheimers Dis. 42 Suppl. 4 2014 S411 S419
202. C.G. Wong, K.M. Gibson, and O.C. Snead 3rd From the street to the brain: neurobiology of the recreational drug γ-hydroxybutyric acid Trends Pharmacol. Sci. 25 2004 29 34
203. J.D. Wood, W.J. Watson, and A.J. Ducker The effect of hypoxia on brain γ-aminobutyric acid levels J. Neurochem. 15 1968 603 608
204. H. Xie, J. Guan, L.A. Borrelli, J. Xu, A. Serrano-Pozo, and B.J. Bacskai Mitochondrial alterations near amyloid plaques in an Alzheimer's disease mouse model J. Neurosci. 33 2013 17042 17051
205. W. Xu, H. Yang, Y. Liu, Y. Yang, P. Wang, S.H. Kim, and et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases Cancer Cell 19 2011 17 30
206. J. Yang, and J. Shen Elevated endogenous GABA concentration attenuates glutamate-glutamine cycling between neurons and astroglia J. Neural Transm. 116 2009 291 300
207. J. Yao, R.W. Irwin, L. Zhao, J. Nilsen, R.T. Hamilton, and R.D. Brinton Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 106 2009 14670 14675
208. J. Yao, J.R. Rettberg, L.P. Klosinski, E. Cadenas, and R.D. Brinton Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions Mol. Asp. Med. 32 2011 247 257
209. P.A. Yates, V.L. Villemagne, K.A. Ellis, P.M. Desmond, C.L. Masters, and C.C. Rowe Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations Front. Neurol. 4 2014 205
210. P. Yogeeswari, D. Sriram, and J. Vaigundaragavendran The GABA shunt: an attractive and potential therapeutic target in the treatment of epileptic disorders Curr. Drug Metab. 6 2005 127 139
211. B.E. Yoon, and C.J. Lee GABA as a rising gliotransmitter Front. Neural Circuits 8 2014 141
212. B.E. Yoon, J. Woo, Y.E. Chun, H. Chun, S. Jo, J.Y. Bae, and et al. Glial GABA, synthesized by monoamine oxidase B, mediates tonic inhibition J. Physiol. 592 2014 4951 4968
213. G.F. Zhang, R.S. Kombu, T. Kasumov, Y. Han, S. Sadhukhan, J. Zhang, and et al. Catabolism of 4-hydroxyacids and 4-hydroxynonenal via 4-hydroxy-4-phosphoacyl-CoAs J. Biol. Chem. 284 2009 33521 33534
214. G.F. Zhang, S. Sadhukhan, R.A. Ibarra, S.M. Lauden, C.Y. Chuang, S. Sushailo, and et al. Metabolism of γ-hydroxybutyrate in perfused rat livers Biochem. J. 444 2012 333 341
215. X. Zhang, and W. Le Pathological role of hypoxia in Alzheimer's disease Exp. Neurol. 223 2010 299 303
216. B.V. Zlokovic The blood-brain barrier in health and chronic neurodegenerative disorders Neuron 57 2008 178 201